- Home
- / IntroMedic
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
IntroMedic financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
₩10.4 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 9.9B | 8.8B | 6.0B | 7.9B | 12.1B | 10.2B | 10.4B |
| Cost of goods sold | 4.0B | 2.8B | 1.7B | 2.9B | 4.8B | 3.8B | 3.6B |
| Gross profit | 7.5B | 8.1B | 6.9B | 5.3B | 7.4B | 6.6B | 7.0B |
| Gross profit margin, % | 76.1% | 91.3% | 116.3% | 67.5% | 61.5% | 65.4% | 67.7% |
| Operating expense total | 9.1B | 9.4B | 8.7B | 9.2B | 10.3B | 10.9B | 8.0B |
| Depreciation and amortization | 6.5B | 738.7M | 1.1B | 1.0B | 1.9B | 317.4M | |
| EBITDA | (1.6B) | (3.6B) | (3.0B) | (2.1B) | (2.9B) | (4.2B) | (939.6M) |
| EBITDA margin, % | -16.0% | -40.9% | -50.6% | -26.8% | -24.0% | -41.3% | -9.0% |
| EBIT | (3.8B) | (13.0B) | (5.0B) | (4.9B) | (6.6B) | (6.7B) | (6.3B) |
| EBIT margin, % | -38.3% | -147.0% | -83.9% | -62.2% | -54.9% | -65.8% | -60.9% |
| Interest income | 748.0M | 1.1B | 834.9M | 1.1B | 213.4M | 248.8M | 64.7M |
| Interest expense | 2.0B | 2.3B | 1.8B | 1.8B | 2.1B | 2.9B | 587.4M |
| Pre tax profit | (5.1B) | (19.3B) | (7.3B) | (13.9B) | (34.3B) | (6.9B) | (5.7B) |
| Income tax expense | 1.4M | 25.4M | 5.9M | 20.1M | 8.1M | (1.4M) | |
| Net Income | (5.1B) | (19.3B) | (7.4B) | (13.9B) | (34.3B) | (6.9B) | (5.7B) |